← brief for 2026-09-03 · Slowing decline

[Systematic review and Meta-analysis of efficacy and safety of Kunxian Capsules in treatment of glomerular diseases].

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review pooled randomized trials of Kunxian Capsules, a Chinese herbal medicine, for glomerular disease, which is damage to the kidney's filtering units. The authors searched nine research databases through May 2025 and looked at both how well the capsules worked alone and alongside standard drugs, plus their side effects. Pooling many randomized trials is the strongest kind of evidence, but the strength of the answer still depends on the quality of the trials that went in, and this abstract does not give the pooled numbers.

Who did this work

Qin C · Wu YB · Chen WJ · Gao F · Yuan GD · Zhang Q · Tan JC · Chen SZ

Source

Article · PubMed, Reducing protein and albumin in urine · 2026 Aug
https://pubmed.ncbi.nlm.nih.gov/42693030/